Our paper is based on a study that explored the intricate connection between people's diverse fertility journeys, particularly those involving Assisted Reproductive Technology (ART), and their workpla...

Midwest BioCapital, a venture capital firm that invests in early-stage biotech and life science startups, recently announced its launch.

Samsara BioCapital seeks to raise $200M for opportunity fund, having secured $98M from 19 investors. Firm has made 180+ investments since 2017, including Abcuro and Dewpoint.

Mission BioCapital has collected $134 million for its sixth investment fund, according to an SEC document filed Friday morning. The firm invests in early-stage biotech companies like March Biosciences, Tune Therapeutics ...

Gossamer Bio (NASDAQ:GOSS) has entered into an option agreement to acquire Respira Therapeutics, a Samsara BioCapital portfolio company. The deal centers around RT234, a first-in-class inhaled vardenafil powder being developed as an as-needed (PRN) treatment for pulmonary hypertension (PH).As part of the agreement, Gossamer will issue 2.5 million shares upfront and an additional 1.5 million shares upon exercising the acquisition option. The deal includes success-based milestone payments and royalties on potential RT234 sales. During the two-year option period, Gossamer will fund CMC development activities for RT234.

SNIPR BIOME, a clinical-stage biotech company based in Copenhagen, has raised €35 million in Series B funding to support the development of its CRISPR-based

Subscription and open access journals from Sage, the world's leading independent academic publisher.

Scroll Down for the English Version Intro Mi hipótesis es simple: el rol del Estado está mutando. Ya no se trata solo de administrar la vida, como planteaba la biopolítica clásica foucaultiana, sin…

Scroll Down for the English Version Intro Mi hipótesis es simple: el rol del Estado está mutando. Ya no se trata solo de administrar la vida, como planteaba la biopolítica clásica foucaultiana, sin…

Scroll Down for the English Version Intro Mi hipótesis es simple: el rol del Estado está mutando. Ya no se trata solo de administrar la vida, como planteaba la biopolítica clásica foucaultiana, sino de decidir —cada vez con más naturalidad y tecnología— quién merece vivir y quién no. Y lo que antes se decidía desde la moral, ahora se decide desde el cálculo.

My YouTube comments give me great post ideas. This time, on a video about fertility, frequent favorite sparring partner FishareFriendsNotFood972 asked, “Do we want to increase the fertility rate, thou...

Mission BioCapital has expanded its European influence by opening a new office in Copenhagen and partnering with BioInnovation Institute to accelerate life sciences innovation.

PDF | On Jan 1, 2017, K. Fritsch published Toxic pregnancies: Speculative futures, disabling environments, and neoliberal biocapital | Find, read and cite all the research you need on ResearchGate

Mission BioCapital, in collaboration with major sponsors, opens applications for its 2025 Platinum Program, offering $4 million to support biotech innovations.

The Colloquium addresses an international interdisciplinary research audience to present and discuss past, present or future projects by artists, scholars, curators or editors from the fields of art, ...